Neuronal survival, differentiation,and maturation are influenced by soluble trophic agents. The importance of trophic factors has been best demonstrated in the case of nerve growth factor (NGF) and its responsive peripheral neurons. Sequestration of endogenous NGF by appropriately timed injections of NGF antibodies destroys sympathetic and sensory neurons. Identification and characterization of central nervous system (CNS) trophic agents has been hampered by the tiny amounts present in nervous and other tissues. It appears that this problem may be circumvented in the case of basal forebrain cholinergic neurons. NGF injected into the cerebral ventricle of neonatal rats produces dramatic and selective increases in the activity of choline acetyltransferase (ChAT), the neurotransmitter synthetic enzyme for cholinergic neurons. It has been hypothesized that NGF is the endogenous trophic factor for these cells, and a number of observations suggest that this is the case. In this application we propose to determine whether NGF supports the viability and differentiation of developing basal forebrain cholinergic neurons. NGF will be purified by high-performance, reverse-phase liquid chromatography. To determine the nature and pattern of NGF activities in the CNS we will examine several neurochemical markers. These studies will record the response of septohippocampal cholinergic neurons before, during and after the period of synapse formation. An immunoadsorption protocol for ChAT will allow us to examine the mechanism of the NGF effect on ChAT activity. The physiological role of endogenous NGF will be examined during the same developmental stages by intracerebroventricular injections of affinity-purified NGF antibodies. These studies will indicate whether cholinergic neurochemical markers are selectively depressed. If so, we will conduct morphological studies to determine whether NGF antibody effects are associated with loss of basal forebrain cholinergic neurons. Our studies may provide evidence that NGF is an endogenous trophic factor these cells. It is expected that the proposed studies will lead to an improved understanding of the growth and development of CNS cholinergic neurons. It is hoped that they will provide insights regarding the role of trophic factors in the developing CNS. Furthermore, they may indicate the potential physiological consequences of altered synthesis or release of trophic factors and suggest means for evaluating the contribution of such disturbances to neurological disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS024054-02
Application #
3408303
Study Section
Neurology C Study Section (NEUC)
Project Start
1986-07-01
Project End
1989-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Belichenko, Pavel V; Madani, Rime; Rey-Bellet, Lorianne et al. (2016) An Anti-?-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. PLoS One 11:e0152471
Nosheny, R L; Belichenko, P V; Busse, B L et al. (2015) Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiol Dis 77:173-90
Ruparelia, Aarti; Pearn, Matthew L; Mobley, William C (2013) Aging and intellectual disability: insights from mouse models of Down syndrome. Dev Disabil Res Rev 18:43-50
Rodrigues, Elizabeth M; Weissmiller, April M; Goldstein, Lawrence S B (2012) Enhanced ýý-secretase processing alters APP axonal transport and leads to axonal defects. Hum Mol Genet 21:4587-601
Ruparelia, Aarti; Pearn, Matthew L; Mobley, William C (2012) Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome. Curr Opin Neurobiol 22:880-6
Sung, Kijung; Maloney, Michael T; Yang, Jingkun et al. (2011) A novel method for producing mono-biotinylated, biologically active neurotrophic factors: an essential reagent for single molecule study of axonal transport. J Neurosci Methods 200:121-8
Belichenko, Nadia P; Belichenko, Pavel V; Kleschevnikov, Alexander M et al. (2009) The ""Down syndrome critical region"" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29:5938-48
Wu, Chengbiao; Cui, Bianxiao; He, Lingmin et al. (2009) The coming of age of axonal neurotrophin signaling endosomes. J Proteomics 72:46-55
Salehi, A; Faizi, M; Colas, D et al. (2009) Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med 1:7ra17
Chial, Heidi J; Wu, Ruping; Ustach, Carolyn V et al. (2008) Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides. Traffic 9:215-29

Showing the most recent 10 out of 61 publications